Response of single leukemic cells to peptidase inhibitor therapy across time and dose using a microfluidic device

Abstract

Microfluidic single-cell assays of peptide degradation were performed at varying inhibitor doses, and the resulting data were analyzed by regression modeling to reveal biological effects